BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19597103)

  • 1. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
    Sheppard JD; Wertheimer ML; Scoper SV
    Arch Ophthalmol; 2009 Jul; 127(7):852-6. PubMed ID: 19597103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
    Weisberg MP; Sugar J
    Arch Ophthalmol; 2010 Nov; 128(11):1497; author reply 1497-8. PubMed ID: 21060060
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.
    Yoon KC; Heo H; Kang IS; Lee MC; Kim KK; Park SH; Cho KO
    Cornea; 2008 May; 27(4):454-60. PubMed ID: 18434850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical cyclosporine-A versus prednisolone for herpetic stromal keratitis: a randomized controlled trial.
    Peyman A; Nayebzadeh M; Peyman M; Afshari NA; Pourazizi M
    Acta Ophthalmol; 2019 Mar; 97(2):e194-e198. PubMed ID: 30284385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
    Asbell PA
    Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%.
    Rao SN
    Am J Ophthalmol; 2006 Apr; 141(4):771-2. PubMed ID: 16564829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
    Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
    Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
    Wu X; Chen X
    Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
    Heiligenhaus A; Steuhl KP
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):435-8. PubMed ID: 10333113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the inflammatory process in herpetic stromal keratitis: the role of in vivo confocal microscopy.
    Hillenaar T; van Cleynenbreugel H; Verjans GM; Wubbels RJ; Remeijer L
    Ophthalmology; 2012 Jun; 119(6):1102-10. PubMed ID: 22361312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Effect of Topical Tacrolimus Treatment on Herpetic Stromal Keratitis in a Rat Model.
    Eriş E; Yüksel N; Pirhan D; Karadenizli A; Aslan M; Gacar G; Erman G; Subaş C; Uzuner H; Yldz DK; Karaöz E
    Eye Contact Lens; 2016 May; 42(3):163-70. PubMed ID: 25996419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral acyclovir suppresses recurrent epithelial and stromal herpes simplex.
    Langston DP
    Arch Ophthalmol; 1999 Mar; 117(3):391-2. PubMed ID: 10088820
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
    Roberts CW; Carniglia PE; Brazzo BG
    Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis.
    Gündüz K; Ozdemir O
    Ophthalmic Res; 1997; 29(6):405-8. PubMed ID: 9380342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
    Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
    PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of herpes simplex virus stromal keratitis: an evidence-based review.
    Knickelbein JE; Hendricks RL; Charukamnoetkanok P
    Surv Ophthalmol; 2009; 54(2):226-34. PubMed ID: 19298901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Penetrating keratoplasty in active herpes simplex stromal keratitis].
    Dong X; Shi W; Xie L
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):118-20. PubMed ID: 11864405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus keratitis after laser in situ keratomileusis.
    Levy J; Lapid-Gortzak R; Klemperer I; Lifshitz T
    J Refract Surg; 2005; 21(4):400-2. PubMed ID: 16128340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.